Eisai Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals in Japan. The company operates through pharmaceuticals business and other business segments. It offers Lenvima, a multi-kinase inhibitor which is involved in tumor angiogenesis or tumor malignancy; LEQEMBI, a humanized IgG1 monoclonal antibody against amyloid-beta (Aß) protofibrils; and Dayvigo, a novel small molecule compound. The company also provides prescription drugs; and over-the-counter drugs, a...
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 81 3 3817 3700
Address:
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, Japan
